ILUMETRI sol inj 100 mg/1ml stylo prérempli

7680693160019 CH-69316 L04AC17 07.15.0.

Reimbursement limitations:

ILUMETRI3

Psoriasis en plaque sévères:
Traitement de patients adultes atteints de formes sévères de psoriasis en …

ILUMETRI sol inj 100 mg/1ml stylo prérempli
ILUMETRI sol inj 100 mg/1ml stylo prérempli
ILUMETRI sol inj 100 mg/1ml stylo prérempli
1 / 3
google

Details

Product number
6931601
CPT
-
Packaging group
1
Unit
Injektor(en), vorgefüllt/Pen
Composition
tildrakizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Ilumetri, 100 mg/1 ml, Injektionslösung im Fertigpen
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/02/2024
Patient information leaflet
Français
19/02/2024
Patient information leaflet
Italien
19/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3238.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2024

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
69316
Drug name
Ilumetri, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AC17
Authorization status
Z
Dispensation category
B
First authorization
19/10/2023
Authorization expiration date
18/10/2028
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis bei Erwachsenen

Packaging details

Description (FR)
ILUMETRI sol inj 100 mg/1ml stylo prérempli
Description (DE)
ILUMETRI Inj Lös 100 mg/1ml Fertigpen
Market launch
19/10/2023
Narcotic (BTM)
No